VANCOUVER, British Columbia and LONDON, April 10, 2018 -- PAI Health (formerly Mio Global), a health technology company with proprietary science-based algorithms that prescribe exercise for optimal health, has entered into a collaboration with reinsurer Gen Re.
PAI (Personal Activity Intelligence) is a motivational heart-rate based activity metric proven to reduce cardiovascular disease and lifestyle risk. PAI technology offers insurers advanced behavioural insights and the measurement of individual and population rising risk and health trends.
PAI will work with Gen Re to develop insurance solutions for life and health clients in the global market that drive customer engagement and reduce risk.
“It is significant to be working with Gen Re, a global leader in the insurance industry,” said Peter Taylor, CEO of PAI Health. “Our combined expertise is a powerful collaboration to realize the full potential of PAI, improving consumers’ health and reducing healthcare and insurance costs on a global scale.”
Ross Campbell, Chief Underwriter, Gen Re International Life/Health Research and Development, comments “Collaborations offer a way for insurers to develop digital solutions that will provide policyholders with added value. We see potential for PAI in risk selection and promoting improved health among insurance customers. Working with PAI underlines Gen Re’s commitment to innovation.”
About PAI Health
Personal Activity Intelligence (PAI) is the first scientifically validated metric that provides personalized guidance on how much exercise is needed for optimal health. PAI Health is the new company formerly known as Mio Global, a successful pioneer in heart rate technology and wearables. PAI helps insurers to better manage risk and reduce costs through rising risk indicators of member health. To learn more visit: www.PAIhealth.com
About Gen Re
Gen Re is one of the leading reinsurers in the world, with a strong focus on health and life insurance. With $13 billion in capital and approx. $5.6 billion in premiums, it is one of the leading reinsurers in the world with a global network of offices in key reinsurance markets. To learn more visit: www.genre.com
Media Contacts:
Olivia Catuara
Uproar PR for PAI Health
[email protected]
312-878-4575 x246
Ross Campbell
Chief Underwriter
Life/Health Research & Development
Gen Re, UK
[email protected]


Yindjibarndi Appeals Fortescue Mining Compensation Ruling
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14%
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’
Google Changes EU Spam Policy Amid Antitrust Scrutiny
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question
PayPal Shares Sink as $50 Billion Takeover Bid Collapses
Mercer International Stock Surges 45% on C$20 Million Canada Funding
Itochu Offers $1.56 Billion to Privatize Dentsu Soken
Trump Administration Plans New Drug Pricing Deals With Biotech Firms
Street Poller Media and The Boom of the Street Interview Ad Industry 



